Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email
No recent articles found for the CORONAVIRUS NEWS in HEALTH but below you will find the latest HEALTH NEWS.

Health Latest News

>> BLADDER CANCER

  • My News
  • -
  • All News

6 HOURS AGO - Health Canal

A Must Read - Share

Scientists discover treatment breakthrough for advanced bladder cancer

Scientists from Queen Mary University of London's Barts Cancer Institute have made a breakthrough in developing a new therapy for advanced bladder cancer – for which there have been no major treatment advances in the past 30 years.

Tags: Scientists discover treatment breakthrough for advanced bladder cancer,  Bladder Cancer Latest News

NOV 26, 2014 - BBC

A Must Read - Share

'Exciting' bladder cancer drug trial

A trial to help the immune system fight bladder cancer is showing "exciting" results with tumours completely disappearing in some patients.

Tags: 'Exciting' bladder cancer drug trial,  Bladder Cancer Latest News

6 HOURS AGO - Health Canal

A Must Read - Share

Kirby Institute launches first of its kind PrEP study

Researchers from the Kirby Institute at UNSW will explore what it's like for people who are HIV negative to take a daily dose of TRUVAD, a two drug combination therapy used to treat HIV in Australia, as pre-exposure prophylaxis of HIV (PrEP).

Tags: Kirby Institute launches first of its kind PrEP study,  Hiv Latest News

6 HOURS AGO - Health Canal

A Must Read - Share

Eradicating Ebola with mathematics

The most effective and, perhaps, surprising weapons in our current battle against the spread of diseases like Ebola, HIV and cancer may prove to be mathematics and computation.

Tags: Eradicating Ebola with mathematics,  Hiv Latest News

1 HOUR AGO - Fox News

A Must Read - Share

New 15-minute test for Ebola to undergo trials in West Africa

A new test designed to rapidly diagnose Ebola virus infection is to be tried out at a treatment center for the disease in Guinea, international health charity The Wellcome Trust said on Friday.

Tags: New 15-minute test for Ebola to undergo trials in West Africa,  Ebola Virus Disease Latest News

3 HOURS AGO - Reuters

A Must Read - Share

China drafts policy on emergency Ebola diagnosis, approves products

SHANGHAI (Reuters) - China has drafted a policy on the emergency use of diagnostic products for the Ebola virus disease and clinical trials, the country's drug regulator said on Friday, as the number of people affected globally by the epidemic nears 16,000.

Tags: China drafts policy on emergency Ebola diagnosis, approves products,  Ebola Virus Disease Latest News

10 HOURS AGO - Newsday

A Must Read - Share

U.S. Adult Smoking Rate Drops to New Low: CDC

But certain groups, such as those below poverty level, are lighting up more

Tags: U.S. Adult Smoking Rate Drops to New Low: CDC,  Smoking Latest News

13 HOURS AGO - Seattle Times

A Must Read - Share

U.S. adult smoking rate dips just under 18 percent

It was the lowest percentage of cigarette smokers since an annual survey began keeping track in 1965, according to the authors of a study published in the CDC’s Morbidity and Mortality Weekly Report.

Tags: U.S. adult smoking rate dips just under 18 percent,  Smoking Latest News

NOV 26, 2014 - Yahoo! News

A Must Read - Share

Novartis selling nicotine patch to win U.S. nod for GlaxoSmithKline deal: FTC

WASHINGTON (Reuters) - Novartis AG has agreed to sell its nicotine patch, Habitrol, in order to win U.S. antitrust approval for a consumer healthcare joint venture with Britain's GlaxoSmithKline, the U.S. Federal Trade Commission said on Wednesday. Novartis and GlaxoSmithKline had previously announced that they were creating the venture, and that Glaxo would buy Novartis' vaccines business, excluding flu vaccines. ...

Tags: Novartis selling nicotine patch to win U.S. nod for GlaxoSmithKline deal: FTC,  Novartis Ag Latest News

NOV 25, 2014 - Yahoo! News

A Must Read - Share

Novartis says U.S. FDA extends review period for bone marrow drug

ZURICH (Reuters) - Swiss drugmaker Novartis AG said on Tuesday the U.S.Food and Drug Administration (FDA) had extended a priority review period by up to three months for a new drug application for the treatment of a type of bone marrow cancer. Novartis submitted its application to the FDA for its LBH589 drug, a treatment for multiple myeloma, in March, ...

Tags: Novartis says U.S. FDA extends review period for bone marrow drug,  Novartis Ag Latest News